Maxtra Oral Drops contain Chlorpheniramine Maleate (2mg/ml) and Phenylephrine (5mg/ml), formulated to provide effective relief from symptoms associated with allergic reactions and nasal congestion. Chlorpheniramine Maleate is an antihistamine that works by blocking H1 histamine receptors, thereby reducing the effects of histamine such as itching, swelling, and rashes commonly seen in allergic conditions. Phenylephrine is a selective alpha-1 adrenergic receptor agonist that acts as a decongestant by constricting blood vessels in the nasal mucosa, leading to decreased swelling and improved airflow. Maxtra Oral Drops are indicated for the symptomatic treatment of allergic rhinitis, hay fever, common cold, and other upper respiratory tract allergies presenting with nasal congestion, sneezing, and watery eyes. The combination of these two active ingredients provides a dual mechanism of action, addressing both histamine-mediated allergic symptoms and nasal congestion. The oral drop formulation allows for precise dosing and rapid onset of action. Maxtra Oral Drops should be used as directed by a healthcare professional, with caution advised in patients with hypertension, cardiovascular disorders, or those taking monoamine oxidase inhibitors. Common side effects may include drowsiness, dry mouth, and increased blood pressure. Consultation with a physician is recommended before use, especially in children, pregnant, or lactating women.